Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals

This cross-sectional study assesses the availability of the direct oral anticoagulant reversal agents idarucizumab and andexanet alfa in US hospitals.

Detalles Bibliográficos
Autores principales: Kanjee, Zahir, McCann, Marissa L., Freed, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122227/
https://www.ncbi.nlm.nih.gov/pubmed/33988710
http://dx.doi.org/10.1001/jamanetworkopen.2021.10079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122227/
https://www.ncbi.nlm.nih.gov/pubmed/33988710
http://dx.doi.org/10.1001/jamanetworkopen.2021.10079

Ejemplares similares